CNSY:NASDAQ
Cerenome, Inc.
$2.76
arrow_downward
-7.55%(-0.22) 1D
$2.85
arrow_upward
+3.52% (+0.097)bedtimeAfter hours
Closed: Sep 4, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CNSY...
Open
$2.89
High
$3.00
Low
$2.74
Mkt. cap
20.91M
Avg. vol.
62.52K
Volume
35.29K
52-wk high
$4.16
52-wk low
$2.62
EPS
-$4.42
Beta
1.39
Shares outstanding
7.59M
No. of employees
28
Open
$2.89
High
$3.00
Low
$2.74
Mkt. cap
20.91M
Avg. vol.
62.52K
Volume
35.29K
52-wk high
$4.16
52-wk low
$2.62
EPS
-$4.42
Beta
1.39
Shares outstanding
7.59M
No. of employees
28
Profile
Cerenome, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Cerenome also commercialized a molecular diagnostic service, CNSide®. Wikipedia
About Cerenome, Inc.